Identifying women with early-stage cervical cancer at low risk of lymph node metastases, in a large international cohort - A logistic regression analysis, without sharing privacy-sensitive patient data
ESGO eAcademy, Hans Wenzel,
373713
The impact of histology, prior therapy, and dMMR status on lenvatinib + pembrolizumab outcomes in patients with advanced endometrial cancer: A subgroup analysis of Study 309/KEYNOTE-775
ESGO eAcademy, Domenica Lorusso,
373689
Comparison of the effect of levonorgestrel-intrauterine system with or without oral megestrol acetate on fertility-preserving treatment in patients with atypical endometrial hyperplasia: a prospective, open-label, randomized controlled phase
ESGO eAcademy, Zhiying Xu,
373687
Major achievements in the management of ovarian cancer (SOLO1, PAOLA1, PRIMA, ATHENAmono, Atalante)
ESGO eAcademy, Mansoor Raza Mirza,
373679
Advances in endometrial & cervical cancers (ENGOT-EN6, KN775, KN826, EMPOWER, ENGOT-CX6)
ESGO eAcademy, Nicoletta Colombo,
373678